Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.22 USD | +0.62% | +2.78% | +0.01% |
01-15 | Gilead Sciences, US government settle patent case over HIV prevention drugs | RE |
01-13 | Gilead to Seek M&A | CI |
Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG MSCI | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
AAA | 114B | ||||||||
A | 682B | ||||||||
AAA | 369B | ||||||||
A | 356B | ||||||||
A | 307B | ||||||||
A | 255B | ||||||||
A | 237B | ||||||||
AA | 206B | ||||||||
AA | 199B | ||||||||
A | 150B | ||||||||
A | 145B | ||||||||
BBB | 126B | ||||||||
A | 114B | ||||||||
AA | 70.13B | ||||||||
AA | 67.32B | ||||||||
AAA | 49.4B | ||||||||
A | 41.27B | ||||||||
A | 40.95B | ||||||||
A | 37.2B | ||||||||
Average | AA | 187.66B | |||||||
Weighted average by Cap. | AA |
- Stock Market
- Equities
- GILD Stock
- Sector Gilead Sciences, Inc.
- Sector ratings
MarketScreener is also available in this country: United States.
Switch edition